# Janus Henderson Investors' Biotech Investments: 89 Startups in Its Portfolio (2026) > The 89 Biotech startups Janus Henderson Investors has backed, by stage: $21B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/janus-henderson-investors-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 41 - [Definium Therapeutics](https://millionrounds.com/company/definium-therapeutics) - [Structure Therapeutics](https://millionrounds.com/company/structure-therapeutics) - [Tyra Biosciences](https://millionrounds.com/company/tyra-biosciences) - [Phathom Pharmaceuticals](https://millionrounds.com/company/phathom-pharmaceuticals) - [Nuvalent](https://millionrounds.com/company/nuvalent) - [Enliven Therapeutics](https://millionrounds.com/company/enliven-therapeutics) - [New Amsterdam Pharma](https://millionrounds.com/company/new-amsterdam-pharma) - [Immunic Therapeutics](https://millionrounds.com/company/immunic-therapeutics) - [Janux Therapeutics](https://millionrounds.com/company/janux-therapeutics) - [*DT* Dice Therapeutics](https://millionrounds.com/company/dice-therapeutics) - [4D Molecular Therapeutics](https://millionrounds.com/company/4d-molecular-therapeutics) - [Centessa Pharmaceuticals](https://millionrounds.com/company/centessa-pharmaceuticals) - [Nkarta Therapeutics](https://millionrounds.com/company/nkarta-therapeutics) - [CG Oncology](https://millionrounds.com/company/cg-oncology) - [Forte Biosciences](https://millionrounds.com/company/forte-biosciences) - [LEXEO Therapeutics](https://millionrounds.com/company/lexeo-therapeutics) - [Tenpoint Therapeutics](https://millionrounds.com/company/tenpoint-therapeutics) - [AtaiBeckley](https://millionrounds.com/company/ataibeckley) - [*2B* 2seventy bio](https://millionrounds.com/company/2seventy-bio) - [C4 Therapeutics](https://millionrounds.com/company/c4-therapeutics) - [ITeos Therapeutics](https://millionrounds.com/company/iteos-therapeutics) - [Pepgen](https://millionrounds.com/company/pepgen) - [Pyxis Oncology](https://millionrounds.com/company/pyxis-oncology) - [Climb Bio](https://millionrounds.com/company/climb-bio) +17 more ## Series C and later 21 - [Kymera Therapeutics](https://millionrounds.com/company/kymera-therapeutics) - [Avidity Biosciences](https://millionrounds.com/company/avidity-biosciences) - [Tubulis](https://millionrounds.com/company/tubulis) - [Encoded Therapeutics](https://millionrounds.com/company/encoded-therapeutics) - [Galecto](https://millionrounds.com/company/galecto) - [Solid Biosciences](https://millionrounds.com/company/solid-biosciences) - [Star Therapeutics](https://millionrounds.com/company/star-therapeutics) - [Obsidian Therapeutics](https://millionrounds.com/company/obsidian-therapeutics) - [IGM Biosciences](https://millionrounds.com/company/igm-biosciences) - [Decibel Therapeutics](https://millionrounds.com/company/decibel-therapeutics) - [Magenta Therapeutics](https://millionrounds.com/company/magenta-therapeutics) - [Lycia Therapeutics](https://millionrounds.com/company/lycia-therapeutics) - [Triveni Bio](https://millionrounds.com/company/triveni-bio) - [Alpha-9 Oncology](https://millionrounds.com/company/alpha-9-oncology) - [Scorpion Therapeutics](https://millionrounds.com/company/scorpion-therapeutics) - [ILiAD Biotechnologies](https://millionrounds.com/company/iliad-biotechnologies) - [Synthekine](https://millionrounds.com/company/synthekine) - [Epicrispr Biotechnologies](https://millionrounds.com/company/epicrispr-biotechnologies) - [*BD* Black Diamon Therapeutics](https://millionrounds.com/company/black-diamon-therapeutics) - [Parse Biosciences](https://millionrounds.com/company/parse-biosciences) - [*S* Sojournix](https://millionrounds.com/company/sojournix) ## Series B 17 - [*B* BioNTech](https://millionrounds.com/company/biontech) - [Kailera Therapeutics](https://millionrounds.com/company/kailera-therapeutics) - [Akero Therapeutics](https://millionrounds.com/company/akero-therapeutics) - [Artiva Biotherapeutics](https://millionrounds.com/company/artiva-biotherapeutics) - [Windward Bio](https://millionrounds.com/company/windward-bio) - [Quell Therapeutics](https://millionrounds.com/company/quell-therapeutics) - [Stoke Therapeutics](https://millionrounds.com/company/stoke-therapeutics) - [Gracell Biotechnologies](https://millionrounds.com/company/gracell-biotechnologies) - [Annexon Biosciences](https://millionrounds.com/company/annexon-biosciences) - [Aktis Oncology](https://millionrounds.com/company/aktis-oncology) - [Black Diamond Therapeutics](https://millionrounds.com/company/black-diamond-therapeutics) - [Graphite Bio](https://millionrounds.com/company/graphite-bio) - [Chroma Medicine](https://millionrounds.com/company/chroma-medicine) - [ProfoundBio](https://millionrounds.com/company/profoundbio) - [*DP* DTx Pharma](https://millionrounds.com/company/dtx-pharma) - [Cedilla Therapeutics](https://millionrounds.com/company/cedilla-therapeutics) - [*AT* Aprea Therapeutics](https://millionrounds.com/company/aprea-therapeutics) ## Series A 10 - [Tango Therapeutics](https://millionrounds.com/company/tango-therapeutics) - [Disc Medicine](https://millionrounds.com/company/disc-medicine) - [Verve Therapeutics](https://millionrounds.com/company/verve-therapeutics) - [Neurogene](https://millionrounds.com/company/neurogene) - [Ottimo Pharma](https://millionrounds.com/company/ottimo-pharma) - [Caribou Biosciences](https://millionrounds.com/company/caribou-biosciences) - [Ambros Therapeutics](https://millionrounds.com/company/ambros-therapeutics) - [Think Bioscience](https://millionrounds.com/company/think-bioscience) - [Third Arc Bio](https://millionrounds.com/company/third-arc-bio) - [Oak Hill Bio](https://millionrounds.com/company/oak-hill-bio) ## Segment by segment ### Stage not reported 41 startups · $8.8B raised - [**Definium Therapeutics**](https://millionrounds.com/company/definium-therapeutics) Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses. United States $805M - [**Structure Therapeutics**](https://millionrounds.com/company/structure-therapeutics) Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR. United States $748M - [**Tyra Biosciences**](https://millionrounds.com/company/tyra-biosciences) Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs. United States $600M - [**Phathom Pharmaceuticals**](https://millionrounds.com/company/phathom-pharmaceuticals) Phathom Pharmaceuticals is a biopharmaceutical company. United States $530M - [**Nuvalent**](https://millionrounds.com/company/nuvalent) Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines. United States $500M - [**Enliven Therapeutics**](https://millionrounds.com/company/enliven-therapeutics) Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives. United States $460M - [**New Amsterdam Pharma**](https://millionrounds.com/company/new-amsterdam-pharma) New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases. Netherlands $453M - [**Immunic Therapeutics**](https://millionrounds.com/company/immunic-therapeutics) Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies. United States $400M ### Series C and later 21 startups · $5.4B raised - [**Kymera Therapeutics**](https://millionrounds.com/company/kymera-therapeutics) Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. United States $799M - [**Avidity Biosciences**](https://millionrounds.com/company/avidity-biosciences) Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector. United States $790M - [**Tubulis**](https://millionrounds.com/company/tubulis) Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment. Germany $401M - [**Encoded Therapeutics**](https://millionrounds.com/company/encoded-therapeutics) Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies. United States $379M - [**Galecto**](https://millionrounds.com/company/galecto) Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer. Denmark $365M - [**Solid Biosciences**](https://millionrounds.com/company/solid-biosciences) Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy. United States $333M - [**Star Therapeutics**](https://millionrounds.com/company/star-therapeutics) Star Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018. United States $325M - [**Obsidian Therapeutics**](https://millionrounds.com/company/obsidian-therapeutics) Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy. United States $210M ### Series B 17 startups · $4.4B raised - [*B* **BioNTech**](https://millionrounds.com/company/biontech) Germany $687M - [**Kailera Therapeutics**](https://millionrounds.com/company/kailera-therapeutics) Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management. United States $600M - [**Akero Therapeutics**](https://millionrounds.com/company/akero-therapeutics) Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state. United States $502M - [**Artiva Biotherapeutics**](https://millionrounds.com/company/artiva-biotherapeutics) Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies. United States $420M - [**Windward Bio**](https://millionrounds.com/company/windward-bio) Windward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committed Switzerland $365M - [**Quell Therapeutics**](https://millionrounds.com/company/quell-therapeutics) Quell Therapeutics is a cell therapy company United Kingdom $274M - [**Stoke Therapeutics**](https://millionrounds.com/company/stoke-therapeutics) Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment. United States $255M - [**Gracell Biotechnologies**](https://millionrounds.com/company/gracell-biotechnologies) Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. China $185M ### Series A 10 startups · $2.1B raised - [**Tango Therapeutics**](https://millionrounds.com/company/tango-therapeutics) Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies. United States $852M - [**Disc Medicine**](https://millionrounds.com/company/disc-medicine) Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders. United States $275M - [**Verve Therapeutics**](https://millionrounds.com/company/verve-therapeutics) Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease. United States $202M - [**Neurogene**](https://millionrounds.com/company/neurogene) Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders. United States $194M - [**Ottimo Pharma**](https://millionrounds.com/company/ottimo-pharma) Ottimo Pharma is a private, clinical-stage biotechnology company based in Sandwich, Kent, United Kingdom. United Kingdom $140M - [**Caribou Biosciences**](https://millionrounds.com/company/caribou-biosciences) Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology. United States $139M - [**Ambros Therapeutics**](https://millionrounds.com/company/ambros-therapeutics) Ambros Therapeutics is a clinical-stage biotechnology company. United States $125M - [**Think Bioscience**](https://millionrounds.com/company/think-bioscience) Think Bioscience is a synthetic biology company located in Boulder, Colorado. United States $55M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Janus Henderson Investors as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Janus Henderson Investors' Pharma portfolio** 35 startups · $6.2B](https://millionrounds.com/portfolio-maps/janus-henderson-investors-pharma-portfolio)[Portfolio map **Janus Henderson Investors portfolio map** 128 startups · $28B](https://millionrounds.com/portfolio-maps/janus-henderson-investors-portfolio-map)[Investments abroad **Janus Henderson Investors' investments in the United States** 111 startups · $23B](https://millionrounds.com/portfolio-maps/janus-henderson-investors-investments-united-states)[Co-investors **Who invests with Janus Henderson Investors** 80 co-investors](https://millionrounds.com/portfolio-maps/janus-henderson-investors-co-investors)[Sector portfolio **DST Global's AI portfolio** 30 startups · $203B](https://millionrounds.com/portfolio-maps/dst-global-ai-portfolio)[Sector portfolio **DST Global's Fintech portfolio** 23 startups · $18B](https://millionrounds.com/portfolio-maps/dst-global-fintech-portfolio) ## Raising from investors like Janus Henderson Investors? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)